Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain
- PMID: 31851569
- PMCID: PMC7482888
- DOI: 10.1080/21645515.2019.1690884
Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain
Abstract
Since the early 2000s, pneumococcal conjugate vaccines (PCVs) have been shown to be effective in the prevention of pneumonia and invasive pneumococcal diseases. In 2011, the Galician region incorporated PCV in the routine infant immunization, the very first stable program in Spain. We aim to assess direct and indirect benefits of PCV vaccination on all-cause pneumonia in the region across different age groups using an ecological study design. For this, we calculated the annual hospitalization rates using a hospital-based disease registry. We identified all-cause pneumonia, pneumococcal pneumonia and pneumococcal invasive diseases within the registry. Hospitalization rates were computed and compared across three study periods: pre-vaccination (1998-2003), early-vaccination (2005-2009) and routine-vaccination (2011-2015). Across Northern Spain, we identified 114,873 all-cause pneumonia hospitalizations, of which 24,808 were further diagnosed with pneumococcal pneumonia. The majority were elderly > 64 years (67.3%). Hospitalizations from all-cause pneumonia had a net increase from 20.6 (pre-PCV) and 21.4/10,000 (early) to 28.4/10,000 (routine) (+32.7%, p < .0001), this is attributed to the huge number of cases in the elderly age group. In contrast, a net reduction of incidence of hospitalized pneumococcal pneumonia was observed from 6.3/10,000 (pre-PCV) and 5.7/10,000 (early) to 2.4/10,000 (routine) cases (-57.9%, p < .0001). Thus, routine infant vaccination may have resulted to an overall decline of pneumococcal pneumonia in infants, as well as in elderly age groups. However, a paradoxical increase on all-cause pneumonia was observed in Galicia, mostly attributed to the growing number of cases in the elderly population.
Keywords: Conjugate vaccines; Spain; Streptococcus pneumoniae; invasive pneumococcal disease; pneumococcal vaccines; pneumococcus; pneumonia; vaccination.
Figures


Similar articles
-
Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.BMC Infect Dis. 2016 Aug 9;16:390. doi: 10.1186/s12879-016-1693-x. BMC Infect Dis. 2016. PMID: 27506837 Free PMC article.
-
Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine.Hum Vaccin Immunother. 2022 Nov 30;18(6):2128566. doi: 10.1080/21645515.2022.2128566. Epub 2022 Oct 14. Hum Vaccin Immunother. 2022. PMID: 36239615 Free PMC article.
-
Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.Vaccine. 2020 Oct 21;38(45):7033-7039. doi: 10.1016/j.vaccine.2020.09.032. Epub 2020 Sep 25. Vaccine. 2020. PMID: 32981782
-
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.Expert Rev Vaccines. 2019 Apr;18(4):327-341. doi: 10.1080/14760584.2019.1582337. Epub 2019 Mar 20. Expert Rev Vaccines. 2019. PMID: 30759352 Free PMC article. Review.
-
The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.Hum Vaccin Immunother. 2016;12(2):314-25. doi: 10.1080/21645515.2015.1084450. Hum Vaccin Immunother. 2016. PMID: 26317537 Free PMC article. Review.
Cited by
-
Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.Hum Vaccin Immunother. 2021 Oct 3;17(10):3670-3686. doi: 10.1080/21645515.2021.1923348. Epub 2021 Jun 9. Hum Vaccin Immunother. 2021. PMID: 34106040 Free PMC article.
-
Antimicrobial Resistance in Pneumococcal Carriage Isolates from Children under 2 Years of Age in Rural Pakistan.Microbiol Spectr. 2021 Dec 22;9(3):e0101921. doi: 10.1128/Spectrum.01019-21. Epub 2021 Dec 22. Microbiol Spectr. 2021. PMID: 34935431 Free PMC article.
-
Efficacy of phentolamine combined with ambroxol aerosol inhalation in the treatment of pediatric severe pneumonia and its effect on serum IL-10 and CRP levels.Transl Pediatr. 2022 Jan;11(1):33-40. doi: 10.21037/tp-21-516. Transl Pediatr. 2022. PMID: 35242650 Free PMC article.
References
-
- Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreno RA, Nohynek H, Riley, ID and Makela, H. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database of Syst Rev. 2009;(4):Cd004977. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical